Ex Parte Freedman et alDownload PDFPatent Trial and Appeal BoardJan 30, 201813843507 (P.T.A.B. Jan. 30, 2018) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/843,507 03/15/2013 Brett A. Freedman 38334-0003003 3284 26191 7590 02/01/2018 FISH & RICHARDSON P.C. (TC) PO BOX 1022 MINNEAPOLIS, MN 55440-1022 EXAMINER TREYGER, ILYA Y ART UNIT PAPER NUMBER 3761 NOTIFICATION DATE DELIVERY MODE 02/01/2018 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): PATDOCTC@fr.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte BRETT A. FREEDMAN, ROBERT L. PAULY, and J&M SHULER MEDICAL, INC. Appeal 2017-003182 Application 13/843,507 Technology Center 3700 Before: STEVEN D.A. MCCARTHY, CHARLES N. GREENHUT, and MICHELLE R. OSINSKI, Administrative Patent Judges. GREENHUT, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Appellants appeal under 35 U.S.C. § 134 from a rejection of claims 15—32. We have jurisdiction under 35 U.S.C. § 6(b). We reverse. Appeal 2017-003182 Application 13/843,507 CLAIMED SUBJECT MATTER The claims are directed to a sub-atmospheric wound-care system. Claim 15, reproduced below, is illustrative of the claimed subject matter: A method for treating a wound with a negative pressure wound therapy system, comprising: applying a dressing system to a wound, the dressing system including: a silver impregnated fine mesh layer having a lower face in contact with the wound, a layer of non-woven polymer material engaged with an upper face of the silver- impregnated fine mesh layer, an interface chamber positioned over a central region of the layer of non-woven polymer material opposite from the silver-impregnated fine mesh layer, the interface chamber comprising an upper central coupling to receive a fluid tube and a lower region defining a plurality of rigid air chambers fixedly positioned relative to one another and in fluid communication with the upper central coupling, and a clear adhesive material being affixed to a skin region surround the wound so as to secure the interface chamber, the layer of non- woven polymer material, and the silver-impregnated fine mesh layer in an airtight region over the wound; connecting the fluid tube between the upper central coupling of the interface chamber and an electronic programmable vacuum regulator unit, the electronic programmable vacuum regulator unit having an intake connector configured to accept flow from a wall vacuum source; connecting the intake connector of the electronic programmable vacuum regulator unit to a fluid line coupled to the wall vacuum source so that the dressing system applies negative pressure wound therapy to the wound; and irrigating the wound with intermittent doses of an irrigation fluid that is delivered through the dressing system. App. Br. 12 (Claims Appendix). REJECTIONS Claims 15—25 and 30-32 are rejected under 35 U.S.C. § 103(a) as being unpatentable over Blott (US 8,162,909 B2, iss. Apr. 24, 2012), Heaton 2 Appeal 2017-003182 Application 13/843,507 (US 6,345,623 Bl, iss. Feb. 12, 2002), and Watt (US 2007/0225663 Al, pub. Sept. 27, 2007). Claims 26 and 27 are rejected under 35 U.S.C. § 103(a) as being unpatentable over Blott, Heaton, Watt, and Fleischmann (US 8,376,972 B2, iss. Feb. 19, 2013). Claims 28 and 29 are rejected under 35 U.S.C. § 103(a) as being unpatentable over Blott, Heaton, Watt, and Karpowicz (US 7,438,705 B2, iss. Oct. 21, 2008). OPINION Appellants raise three issues with the Examiner’s rejection of independent claim 15, the sole independent claim before us. First, Appellants argue that the projections 32 of Heaton are not reasonably regarded as the recited “plurality of rigid air chambers” according to claim 15 and the Examiner’s rejection thereof. App. Br. 6—7. Second, Appellants argue that the imposition of Heaton’s filler, foam 73, between Blott’s irrigation pipes 97 and the wound bed would defeat the purpose of Blott’s irrigation pipes. App. Br. 8—10. Third, Appellants argue that the Examiner cannot rely on a generic teaching of “piped supply of vacuum” to meet a specific limitation directed to “a wall vacuum source.” Appellants are correct on all three points. First, although air channels may be formed between projections 32 in Heaton, that is no reason to regard the projections themselves as “air chambers.”1 Second, Appellants raise a reasonable issue concerning the lack 1 It is noted that the phrase “air chambers” does not appear to have antecedent basis in the Specification, which, in relevant part, describes 3 Appeal 2017-003182 Application 13/843,507 of functionality resulting from the Examiner’s proposed combination, to which the Examiner provides no response. App. Br. 8; Reply Br. 2. Third, although a wall vacuum may be a type of piped vacuum source, a piped vacuum source is not necessarily a wall vacuum source. App. Br. 10; Reply Br. 2. This must be regarded as a difference between the claimed subject matter and the prior art under the Graham inquiry for which the Examiner has not accounted. For these reasons, the rejections cannot be sustained on the basis set forth by the Examiner. DECISION The Examiner’s rejections are reversed. REVERSED “columns of plastic” separating the layers into “uniform air channels.” Spec, para. 35. If the Examiner has not already done so, the Examiner may wish to consider whether the original disclosure provides sufficient support for the phrase “air chambers,” inserted by amendment. Although the Board is authorized to reject claims under 37 C.F.R. § 41.50(b), no inference should be drawn when the Board elects not to do so. See MPEP § 1213.02. 4 Copy with citationCopy as parenthetical citation